Ansun Biopharma Stock

ansunbiopharma.comHealthcareFounded: 2003Funding to Date: $165.2MM

Ansun Biopharma is a late-stage clinical development company dedicated to saving the lives of vulnerable patient populations through the creation of first-in-class biologics.

Register for Details

For more details on financing and valuation for Ansun Biopharma, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Ansun Biopharma.

Register Today


Management Team

Nancy Chang Ph.D
Chief Executive Officer & Chairperson of the Board
Ivy Fan
George Wang
Chief Technology Officer
Mikael Havluciyan
Chief Legal Officer & Corporate Secretary
Stanley Lewis MD
Chief Medical Officer

Board Members

Allen Chao Ph.D
Karen Liu Ph.D
Nancy Chang Ph.D
Aimin Wu
Sinopharm Healthcare Fund
Donald Payne
Michael Chao MD
Dave Chenn
Michael Chang Ph.D
Yi Shi Ph.D
Lilly Asia Ventures

Other companies like Ansun Biopharma in the Healthcare sector

Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation
Last Round Est. Valuation


Ansun aims to drive the global Phase 3 clinical trial of its experimental anti-viral medication.